Although TBMED has come to an end, our Open Innovation Test Bed (OITB) go.Med continues to be alive and active.

Iraida Loinaz and Andrea Haiek are currently presenting go.Med at the CIDETEC booth at...

After more than four and a half years of groundbreaking work, the TBMED project is coming to a successful close at the end of August. The project's main goal was to provide expert support to medical d...

Welcome to SUPERHUMAN, an exhibit celebrating collaboration, creativity and innovation in medical technology (medtech) research in Ireland. This exhibition by CÚRAM (the SFI Research Centre for Medica...

Even the typical Irish weather, changing between sun and clouds and heavy rain in minutes, couldn’t dampen our joy to get all together for one last Progress Meeting before the TBMED project comes to a...

We are very proud to announce that TBMED and its Open Innovation Test Bed (OITB) go.Med are featured in the recent Results Pack on Open Innovation Test Beds, 2nd edition, prepared and published by C...

The TBMED partners are excited to announce the publication of a new animated video clip that introduces the go.Med platform developed in the project. The platform supports developers of high-risk medi...

In January 2021, TBMED launched its second Open Call with the objective to provide support to developers aiming to perform a Clinical Proof of Concept (CPoC) or clinical investigation with an innovati...

With our Open Calls in TBMED we have gained some insight into the challenges that companies – particularly small and medium-sized companies – face in the medical device development process. This proce...

Join stakeholders and policymakers at the EU Knowledge Valorisation Week between 25 April and 28 April 2023. The annual event highlights best practices promoting the uptake of research results and sci...

The TBMED consortium started into the new year with their 8th Progress Meeting in Bilbao on January 16-17, 2023. The partners were kindly welcomed by Ainhoa Martín and Iñaki Gutierrez from BIOEF.

Since its launch in 2019, the Horizon Results Platform has been offering a free, online space where participants in EU-funded projects, such as Horizon 2020 and Horizon Europe, can advertise the resul...

After its premiere at MedFit earlier this year, go.Med made its second appearance at COMPAMED from November 14-17, 2022 in Duesseldorf, Germany.

COMPAMED is one of the largest trade fairs for me...

TBMED’s primary goal is to develop an Open Innovation Test Bed for High-Risk Medical Devices. Recently, our OITB go.Med had it first official appearance at MedFit event in Grenoble, France, on Sep...

On September 4-8, 2022, ESB 2022, the 32nd Annual Conference of the European Society for Biomaterials (ESB), took place in Bordeaux, France. The event, having taken place in person for the first tim...

The European Research and Innovation Days are the European Commission’s annual flagship Research and Innovation event, bringing together policymakers, researchers, entrepreneurs and the public to deba...

It still seems unreal but it actually happened: After 2.5 long years of online meetings, the TBMED consortium finally met in person again on June 28-29, 2022.

Despite some travel problems includin...

Due to long reimbursement processes, patient access to innovative high-risk medical devices can take very long. In addition, the new EU Medical Devices Regulation (2017/745) is imposing stricter requi...

We are happy to announce that Andrea Haiek from TBMED coordinator CIDETEC will join the OITB workshop at IndTech 2020 (Conference on Industrial Technologies) representing the TBMED project and its OIT...

Medical device development, from conception to timely release to market, can be expensive and risky. This is particularly true for high-risk medical devices affected by the EU’s current Regulation 201...

Developing a medical device (MD) is a complex and often challenging process. This is particularly true for high-risk medical devices affected by the EU’s current regulation 2017/745. Providing a full...

In preparation of the upcoming launch of our Open Innovation Test Bed (OITB) go.Med by the end of 2022 we have created a brand-new subpage on our TBMED website explaining to medical device developers...

May it be that the second half of a project is always running faster than the first? It seemed like yesterday that we had our last Progress Meeting although half a year had past before the entire TBME...

While Regulation (EU) 2017/745 came into force already on 25 May 2017, originally approved medical devices had a transition time of three years to meet new requirements. Since May 26, 2021, the new re...

Developing a medical device (MD) is a complex and often challenging process. This is particularly true for high-risk medical devices affected by the EU’s current regulation 2017/745.

The process of...

Dr Raluca Fratila from TBMED partner UNIZAR gave a talk about the use of magnetic heating for therapy and the TBMED project in the Workshop “Designing MNPs for nanoactuation based on magnetic heating...

Glycobone – an injectable ready-to-use polysaccharide-based scaffold combined with hydroxyapatite tailored for oral bone defect reconstruction – is one of the use cases developed in TBMED by SILAB’s s...

What happens when artists meet scientists? UNIZAR team members Lucía Gutiérrez and Raluca Fratila wanted to know and joined the “NanoAsalto” project, which uses art as a vehicle to communicate science...

TBMED started the new year and the second half of the project’s duration with its 4th Progress Meeting held virtually on January 27-28, 2021. Despite working under the persistent constraints of the Co...

TBMED launches an Open Call with the objective of providing support to developers which aim to perform a Clinical Proof of Concept (CPoC) or clinical investigation with an innovative high risk medical...

Small and Medium-sized Enterprises (SMEs) as well as other businesses were put at high risk by the economic slowdown caused by the COVID-19 pandemic across Europe. Consequently, the three EU funded Me...

It is amazing how time flies: the first 18 months of our TBMED project are already over. The end of our first project period came along with our first review meeting. Contrary to our plans at the begi...

Within the scope of their 2nd Progress Meeting, the TBMED continued its series of so-called Open Sessions in Zaragoza, Spain on January 15, 2020. Among the companies and clusters joining the session a...

While the new year is still young, the TBMED consortium is already working at full force and came together for the project’s 2nd Progress Meeting and an Open Session in Zaragoza, Spain on January 15-1...

Iraida Loinaz will join the team of the European IP Helpdesk in Brussels on November 26, 2019 to present TBMED during the initiative’s annual stakeholder meeting. The European IP Helpdesk is a servi...

We are happy to announce that TBMED has joined the Twitter community. You can now follow us on @TBMED_EU.

We are looking forward to exchanging our ideas with you and keep you informed about the la...

Half a year into the project, the TBMED consortium met in Paris, France for their 1st Progress Meeting on July 9-10, 2019. The meeting was hosted by Didier Letourneur and his team from TBMED partner I...

June was a busy month for TBMED as the project was presented for the first time after its start at two major European events.

At EuroNanoForum on June 12-14, 2019, TBMED was part of the “Safe by D...

The new EU research project TBMED aims to support European med-tech companies in global competition by reducing the time-to-market of high-risk medical devices (MD). An Open Innovation test bed for th...